secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001193125-22-178755
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma Director Cameron Gray Resigns from Board
------------------------------------------------------

- Cameron Gray notified Cue Biopharma of his resignation as a Board member on June 16, 2022.
- Gray also resigned from all board committees, effective immediately.
- The resignation was not related to any disagreement with the company on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522178755/0001193125-22-178755-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522178755/d535327d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-178755

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer